(Q33244246)

24 July 2017

Possible isotretinoin-induced keloids in a patient with Behçet's disease (English)

1 reference

24 July 2017

0 references

Dogan G

1

1 reference

24 July 2017

1 July 2006

1 reference

Clinical and Experimental Dermatology

24 July 2017

1 reference

24 July 2017

31

1 reference

24 July 2017

4

1 reference

24 July 2017

535-537

1 reference

Behçet's disease: an enigmatic vasculitis

24 July 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2006.02140.X

The molecular basis of keloid and hypertrophic scar formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2006.02140.X

Serum interleukin-6, procalcitonin and C-reactive protein levels in subjects with active Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2006.02140.X

Keloid formation induced by isotretinoin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2006.02140.X

Elevated interleukin-6 expression in keloid fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2006.02140.X

Interleukin-6 (IL-6) in patients with Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2006.02140.X

Global gene expression analysis of keloid fibroblasts in response to electron beam irradiation reveals the involvement of interleukin-6 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2006.02140.X

Electrodermal activities and autonomic nervous system in Behçet's patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2006.02140.X

10.1111/J.1365-2230.2006.02140.X

21 January 2018

Identifiers

DOI

1 reference

24 July 2017

1 reference

PubMed ID

16716157